Manly’s Little Penguins to be Vaccinated for Bird Flu as Priority Species

Written by

Member for Manly, James Griffin MP has welcomed advice from National Parks and Wildlife Services that Manly’s Little Penguin colony will be vaccinated as early as next week to protect them against the H5 avian influenza (bird flu).

After seeking advice from National Parks and Wildlife Services, Mr Griffin has confirmed that the NSW Government is progressing vaccination of priority native wildlife against H5 avian influenza, with Manly’s little penguins identified as a priority species because of their conservation significance and the potential impacts of the virus.

“Our National Parks and Wildlife Rangers and staff do an outstanding job, and I cannot thank them enough for taking such prompt action to get ahead of this and protect our Little Penguins,” Mr Griffin said.

“As the last remaining breeding colony on mainland NSW, Manly’s Little Penguins are one of the state’s most vulnerable bird species, and I am deeply concerned about the threat posed by the outbreak of H5 bird flu.”

“I also wish to take this opportunity to thank our local volunteer penguin wardens, who dedicate their time to patrol breeding areas every night from the beginning of the season and monitor the health of the colony.”

Detailed planning has considered animal welfare, disease risk, conservation benefit, biosecurity, monitoring and the practical requirements for safely delivering the vaccine.

Vaccination of the Manly’s Little Penguin colony will be delivered alongside a broader response to H5 bird flu, with National Parks and Wildlife Services and partner agencies continuing surveillance, preparedness and biosecurity activities to support protection of the Manly population.

Other wildlife facilities across NSW will join the state’s vaccine program, ensuring as many species as possible can be covered.

Members of the public should continue to avoid handling sick or dead birds and report suspected cases to the Emergency Animal Disease Hotline on 1800 675 888.

Last modified: August 30, 2026